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Abstract: Euonymus laxiflorus Champ., a medicinal herb collected in Vietnam, has been reported
to show several potent bioactivities, including anti-NO, enzyme inhibition, hypoglycemic and
antidiabetic effects. Recently, the antioxidant activity of Euonymus laxiflorus Champ. trunk bark
(ELCTB) has also been reported. However, the active antioxidant and anti-NO constituents existing
in ELCTB have not been reported in the literature. The objective of this study was to purify the active
antioxidants from ELCTB and investigate the anti-NO effect of the major constituents. Twenty-two
phenolics isolated from ELCTB, including 12 compounds newly isolated in this study (1–12) and
10 constituents obtained from our previous work, were evaluated for their antioxidant activity.
Of these, 12 compounds (4–6, 9, 13–15, 18–22) showed a potent antioxidant capacity (FRS50 =
7.8–58.11 µg/mL), in comparison to α-tocopherol (FRS50 = 23 µg/mL). In the anti-NO activity tests,
Walterolactone A (1a) and B (1b) β-D-glucopyranoside (13) demonstrated the most effective and
comparable activity to that of quercetin with max inhibition and IC50 values of 100%, 1.3 µg/mL, and
100%, 1.21 µg/mL, respectively. The crude extract and its major compounds showed no cytotoxicity
on normal cells. Notably, three constituents (9, 11, and 12) were identified as new compounds,
another three constituents, including 1, 7, and 8, were found to be new natural products, constituents
9 and 13 were determined to be new antioxidants, and compound 13 was reported to have novel
potent anti-NO activity for the first time. The results of this study contribute to the enrichment of
new natural products and compounds, as well as the novel biological activity of constituents isolated
from Euonymus laxiflorus Champ. The current study also indicates ELCTB as a rich natural source of
active phenolics. It is suggested that ELCTB could be developed as a health food with promising
antioxidant and anti-NO effects, as well as other beneficial biological activities.
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1. Introduction
Living organisms are negatively affected by free radicals in areas such as DNA, proteins, and
lipid damage, and as such, they may cause various diseases [1]. These unexpected effects can be
reduced and prevented by antioxidant compounds which can be synthesized or obtained from natural
resources. However, synthetic antioxidants can cause carcinogenesis and liver damage [2]. Thus,
the discovery of abundant and natural antioxidants is still needed. Antioxidants may be obtained
from several natural sources, including higher plants [3–5], microbial fermentation [6,7], and marine
products [8,9]. Of these, herbal antioxidants have been given much exploration in recent years [10].
Vietnam is a tropical country and is considered the sixteenth most biodiverse region in the world.
It possesses around 10,000 herbal species, of which 4000 have been used as medicinal plants [11].
Therefore, there has been increased interest in the seeking and purification of bioactive constituents
from Vietnamese herbs in recent years [4,5,10,12–17]. Numerous herbs showing enzymic inhibitory,
hypoglycemic, and antidiabetic effects have been investigated [4,5,12–17]. The antioxidant and
anticancer effects of the herbs collected in this biodiverse region have also been reported in several
works [4,5,10]. However, only a few herbs possessing anti-NO properties have been reported, and
there are also few studies working on the isolation and identification of active compounds (antioxidant
and anti-NO constituents). Thus, the investigation of natural products processing beneficial properties
from the herbs of this biodiverse area has been received with great attention.
Euonymus laxiflorus Champ.—A medicinal herb, is wildly distributed in Vietnam [12,17] and
some other Asian countries, including China, Cambodia, India, and Myanmar [18]. This medicinal
herbal species has been recognized as a rich source of bioactive natural products and has been
extensively investigated to reclaim its potent antidiabetic properties via enzymic inhibition and animal
tests [4,12,13]. These previous studies revealed that Euonymus laxiflorus Champ. shows potency for
α-amylase inhibition [13], α-glucosidase inhibition [12], as well as a significant effect on the reduction
of blood glucose in diabetic rats [4]. Recently, novel potent antidiabetic compounds have been isolated
and identified from Euonymus laxiflorus trunk bark extract [14,17]. Of these, poly condensed tannin,
a major antidiabetic compound, has demonstrated a significant effect on reducing plasma glucose in
ICR mice [17]. Some constituents isolated from the leaves of this plant have shown anti-nitric oxide
and antioxidant effects [19]. However, little data on the antioxidant properties of this herbal extract
exists beyond the previous reports [4], and no compounds isolated from the trunk bark extract of this
herb have been reported for the evaluation of antioxidant and anti-NO capacities.
As a part of the objective to indicate scientific proof for the development of Euonymus laxiflorus
Champ. as potent functional food or drug, this study investigated the bioactivity of this herb to isolate
and identify its chemical constituents. In the current study, the potent antioxidant capacity of Euonymus
laxiflorus Champ. was reclaimed, and the isolation and identification of its active compounds, as well
as an evaluation of its antioxidant and anti-NO activities, were also reported. The results of this study
contributed to the enrichment of new natural products and novel compounds, as well as the new
biological effects of the constituents isolated from Euonymus laxiflorus.
2. Results and Discussion
2.1. Reclamation of Euonymus laxiflorus Champ. Extracts as a Potential Source of Beneficial Bioactive
Properties without Toxicity
The methanol extract of Euonymus laxiflorus Champ. trunk bark (ELCTB) was evaluated for its
DPPH radical scavenging activity (antioxidant activity), and the results are illustrated in Figure 1
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(%) and Table 1 (FRS50). ELCTB showed potent antioxidant activity with great max activity (%) and
low FRS50 values of 97% and 20.2 µg/mL, respectively. The antioxidant activity of α-tocopherol,
a commercial antioxidant compound, was also tested for comparison and showed approximately
equal activity, with max activity (%) and low FRS50 values of 99% and 24.4 µg/mL, respectively.
In the comparison, Euonymus laxiflorus Champ. also showed comparable or higher antioxidant activity
than those of some recently-reported medicinal extracts collected in the central highlands of Vietnam
(Table 1).
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T. bellirica Trunk bark 1020 ± 20 Nguyen et al., 2016 [5] 
T. corticosa Trunk bark 250 ± 0.00 Nguyen et al., 2016 [5] 
L-ascorbic acid *  240 ± 0.00 Nguyen et al., 2016 [5] 
T. nigrovenulosa Bark extract 273 ± 3 Nguyen, Q.V. 2017 [10] 
T. nigrovenulosa Leaves extract 408 ± 6 Nguyen, Q.V. 2017 [10] 
* Commercial antioxidant compounds. 
The trunk bark of Euonymus laxiflorus Champ. has been reported to possess promising α-
glucosidase inhibitory and α-amylase inhibitory activities [12,13] and significant effects on the 
reduction of plasma glucose in normal and diabetic mice [4,17]. The anti-NO activity of the extract 
from the leaves of this herb was investigated by Liu et al. (2014) [19]. In addition, Euonymus laxiflorus 
has been proved to be non-toxic via animal models in previous reports [4]. In this study, ELCTB was 
found to show potential antioxidant activity, therefore an investigation was conducted to isolate and 
identify its active compounds, which were subsequently evaluated for their beneficial bioactivities. 
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2.2. Selective Solvent Extraction for Max Antioxidant Productivity from Euonymus laxiflorus Champ. Extracts
and Purification of Active Compounds
Five solvents, including water, butanol, ethanol, methanol, and ethyl acetate, were used to extract
Euonymus laxiflorus Champ. trunk bark (ELCTB), and then all extracts were evaluated for antioxidant
activity. As shown in Figure 2A, the ELCTB extracted by methanol demonstrated the highest activity
due to its smallest FRS50 value of 20 µg/mL. Therefore, the methanol extract was chosen for the next
step of purification.
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in Figure 2B. Two fractions (ELCTB-2, and ELCTB-3) showed the smallest FRS50 values of 12.25 and 
12.42 µg/mL, respectively, and as such possessed the highest activity. These potent fractions were 
further purified via ODS columns to obtain a total of 20 sub-fractions. Of these, three sub-fractions, 
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Figure 2. Antioxidant activity of the Euonymus laxiflorus Champ. trunk bark (ELCTB) extracted using
different solvents: (A) ELCTB and its fractions after Diaion column; (B) fraction ELCTB-2 and its
sub-fractions; (C) fraction ELCTB-3 and its sub-fractions; (D) after silica columns. The means of FRS50
with different letters in the same figure were significantly different based on Duncan’s multiple range
test at alpha = 0.01.
ELCTB was primary separated via a Diaion column to obtain the five fractions of ELCTB-1
(20.97 g), ELCTB-2 (9.12 g), ELCTB-3 (4.67 g), ELCTB-4 (1.46 g), and ELCTB-5 (1.63 g) through
successive eluting with distilled water, 40% MeOH, 70% MeOH, 100% MeOH, and 100% ethyl acetate,
respectively. The antioxidant activity of ELCTB and these separated fractions were tested as shown
in Figure 2B. Two fractions (ELCTB-2, and ELCTB-3) showed the smallest FRS50 values of 12.25 and
12.42 µg/mL, respectively, and as such possessed the highest activity. These potent fractions were
further purified via ODS columns to obtain a total of 20 sub-fractions. Of these, three sub-fractions,
ELCTB-2.1, ELCTB-2.2, and ELCTB-2.3 were separated from ELCTB-2, and one sub-fraction, ELCTB-3.3,
was separated from ELCTB-3. These sub-fractions possessed significant activity, and as such were
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purified to isolate their constituents. The utilization of preparative HPLC resulted in the isolation of 12
(1–12) compounds from these four active sub-fractions. The isolation process is briefly presented in
Figure 3.
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Figure 3. Isolation chart of the active constituents from Euonymus laxiflorus Champ. trunk bark
(ELCTB) extract. EA: acetyl acetate; MeOH: methanol; Pr-HPLC: preparative high-performance liquid
chromatography; ACN: acetonitrile; ODS: octadecylsilane.
2.3. Identification of Isolated Constituents from Euonymus laxiflorus Champ.
The 12 constituents newly isolated from ELCTB were identified as Umbelactone (1) [20],
Walterolactone (2) [21], Phenylalanine (3) [22], 2-methoxy-4-hydroxyphenol-1-O-β-D-glucopyranoside
(4) [23], 1-β-D-glucopyranosyloxy-3,5-dimethoxy-4-hydroxybenzene (5) [24], (−)-3,4-(Dihydroxybenzoic
acid (6) [25], 2-benzoyl myo-inositol (7) [26], 1-O-Benzoyl-myo-inositol (8) [27], walterolactone A/B
6-O-gallate-β-D-glucopyranoside (9), Roseoside (6S, 9S) (10) [28], (3R*,6R*)-tetrahydro-6-ethenyl-2,2,6-
trimethyl-2H-pyran 3-O-α-L-arabinopyranosyl (1→3)-β-D-glucuronopyranosyl (11), and 7-Hydroxy-
6,7-dihydro-cis/trans- geraniate, 3-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranosyl (12).
Based on the literature review, three compounds, Umbelactone (1), 2-benzoyl myo-inositol (7),
and 1-O-Benzoyl-myo-inositol (8) were found to be new natural products. Notably, walterolactone
A/B 6-O-gallate-β-D-pyranoglucoside (9), (3R*,6R*)-tetrahydro-6-ethenyl-2,2,6-trimethyl-2H-pyran
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3-O-α-L-arabinopyranosyl (1→3)-β-D-glucuronopyranosyl (11), and 7-Hydroxy-6,7-dihydro-cis/trans-
geraniumsaeure 3-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranosyl (12) were identified as new
compounds. Their characteristics and NMR data were recorded as shown below. The results of this
study contributed to the enrichment of new natural products, as well as the enrichment of the novel
constituents of Euonymus laxiflorus Champ.
Walterolactone A/B 6-O-gallate-β-D-pyranoglucoside (9) was obtained as a white amorphous powder.
1H-NMR data (600 MHz, MeOH-d4, δH ppm): 7.05 (s, 2H), 5.81 (brs), 4.58 (dd, J = 12.0, 2.4 Hz), 4.54
(dd, J = 12.6, 3.0 Hz), 4.44 (d, J = 7.8 Hz), 4.39 (dd, J = 12.6, 3.0 Hz), 4.22 (t, J = 3.0 Hz), 4.10 (dd,
J = 12.0, 6.0 Hz), 3.60 (m), 3.4 (m, 2H), 3.2 (m), 2.14 (brs). 13C-NMR data (150 MHz, MeOH-d4, δC
ppm): 168.2, 166.0, 158.2, 146.5, 140.0, 121.4, 118.9, 110.1, 103.3, 77.8, 75.6, 74.7, 71.7, 71.6, 70.6, 64.6, 20.5.
The chemical structure and the key correlations of HMBC and COSY for this compound are shown in
Figure 4.
(3R*,6R*)-tetrahydro-6-ethenyl-2,2,6-trimethyl-2H-pyran 3-O-α-L-arabinopyranosyl (1→3)-β-D-
glucuronopyranosyl (11) was obtained as a white amorphous powder. 1H-NMR data (600 MHz,
MeOH-d4, δH ppm): 5.95 (dd, J = 18.0, 11.2 Hz), 5.05 (d, J = 18.0 Hz), 4.97 (d, J = 1.8 Hz), 4.95 (d,
J = 11.2 Hz), 4.32 (d, J = 7.8 Hz), 4.00 (dd, J = 11.4, 2.4 Hz), 3.98 (dd, J = 3.0, 1.8 Hz), 3.96 (td, J = 5.4,
3.0 Hz), 3.82 (dd, J = 6.0, 3.0 Hz), 3.74 (dd, J = 14.4, 3.0 Hz), 3.64 (dd, J = 14.4, 5.4 Hz), 3.60 (dd, J = 11.4,
6.0 Hz), 3.43 (m), 3.41 (overlapped), 3.32 (overlapped), 3.23 (dd, J = 9.6, 9.0 Hz), 3.12 (dd, J = 9.0,
7.8 Hz), 2.15 (ddd, J = 13.8, 3.0, 2.4 Hz), 1.97 (dq, J = 13.2, 4.2 Hz), 1.75 (qd, J = 13.2, 3.6 Hz), 1.60 (td,
J = 13.8, 2.4 Hz), 1.25 (s, 3 H), 1.18 (s, 3 H), 1.08 (s, 3 H). 13C-NMR data (150 MHz, MeOH-d4, δC ppm):
147.4, 111.5, 109.9, 106.3, 86.0, 85.9, 83.2, 79.0, 78.1, 77.1, 76.6, 75.3, 74.9, 72.0, 68.2, 63.1, 33.6, 32.2, 30.0,
25.8, 22.0. The chemical structure and key correlations of HMBC and COSY for this compound are
shown in Figure 4.
7-Hydroxy-6,7-dihydro-cis/trans-geraniate, 3-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranosyl (12).
1H-NMR data (400 MHz, MeOH-d4, δH ppm): 5.76 (brs), 5.47 (d, J = 8.0 Hz), 4.90 (brs), 3.99 (dd,
J = 11.4, 2.4 Hz), 3.98 (m), 3.96 (m), 3.80 (m), 3.74 (dd, J = 11.4, 3.0 Hz), 3.62 (dd, J = 11.4, 5.4 Hz), 3.59
(dd, J = 11.4, 6.0 Hz), 3.57 (m), 3.42 (t, J = 8.8 Hz), 3.34 (m, 2H), 2.20 (t, J = 6.8 Hz), 2.18 (s, 3 H), 1.57
(m, 2H), 1.43 (m, 2H), 1.17 (s, 6H). 13C-NMR data (100 MHz, MeOH-d4, δC ppm): 166.4, 164.7, 115.9,
110.0, 95.1, 85.7, 83.2, 78.8, 78.0, 77.5, 73.9, 71.6, 71.2, 67.9, 63.0, 44.0, 42.4, 29.2, 23.2, 19.1. The chemical
structure and the key correlations of HMBC and COSY for this compound are shown in Figure 4.
2.4. Evaluation of Antioxidant Activity of Identified Compounds from ELCBT
All of the newly identified compounds (1–12) in this study, as well as the ten compounds (13–22)
obtained from our previous study [14], including walterolactone A (1a) and B (1b) β-D-glucopyranoside
(13), gallic acid (14), (−)-Gallocatechin (15), 1-(4-hydroxyphenyl)-2,3-dihydroxypropan-1-one 3-O-
β-D-glucopyranoside (16), Myo-inositol 1-O-3,3-dimethylacrylate (17), leonuriside (18), (+)-Catechin
(19), methyl galloate (20), (−)-Catechin (21), and (3,5-dimethoxy-4-hydroxyphenol)-1-O-β-D-
(6′-O-galloyl)-glucopyranoside (22) were evaluated for their antioxidant capacity at a concentration
range of 0.5–250 µg/mL. The activity was estimated and expressed as FRS50 values and the max activity
was recorded at 250 µg/mL (Table 2). Of these 22 tested constituents, 6, 9, 14 and 19–22 demonstrated
stronger activity (FRS50 = 7.8–16.77 µg/mL, ranked at the e–f level) than that of α-tocopherol (FRS50
= 23 µg/mL, ranked at the d level); 13 and 18 showed comparable activity (FRS50 = 27.47–28 µg/mL,
ranked at the e–f level) to that of the positive control, since their FRS50 values were ranked at the same
level as cd–d; while 4, 5, and 15 had lower activity (FRS50 = 30.73–58.11 µg/mL, ranked at the a–c
level) than α-tocopherol, based on Duncan’s multiple range test at alpha = 0.01. However, these 12
antioxidants all possessed strong max antioxidant activity (92–100%, ranked at the a level) that was
equal to that of α-tocopherol (99%, ranked at the a level); as such they could be identified as potent
antioxidant compounds. Compounds 11 and 12 possessed weak activity with max activity of 20–25%,
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and the other nine constituents showed no activity. The results indicated that ELCBT was a potentially
rich source of active antioxidant compounds.
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Champ: (a), key correlations of HMBC (heteronuclear multiple bond correlation) and COSY (correlated
spectroscopy) of the three new compounds; (b) Umbelactone (1), Walterolactone (2), Phenylalanine (3),
2-methoxy-4-hydroxyphenol-1-O-β-D-glucopyranoside (4), 1-β-D-glucopyranosyloxy-3,5-dimethoxy-
4-hydroxybenzene (5), 3,4-Dihydroxybenzoic acid (6), 2-benzoyl myo-inositol (7), 1-O-Benzoyl-myo-
inositol (8), walterolactone A/B 6-O-gallate-β-D-glucopyranoside (9), Roseoside (6S, 9S)
(10), (3R*,6R*)-tetrahydro-6-ethenyl-2,2,6-trimethyl-2H-pyran 3-O-α-L-arabinopyranosyl (1→3)-β-D-
glucuronopyranosyl (11), and 7-Hydroxy-6,7-dihydro-cis/trans- geraniate, 3-O-α-L-arabinopyranosyl
(1→6)-β-D-glucopyranosyl (12).
In recent reports, compounds 13–15, 18 and 19 have been reported to show potent α-amylase
inhibito y activity [14], and compounds 13, 15–19 were rec ntly e ermined to be effectiv
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α-glucosidase inhibitors by Nguyen et al., 2018 [17]. Of these, Walterolactone A (1a) and B (1b)
β-D-glucopyranoside (13) was identified as a new compound in a previous study [14]. This study
was the first to report its potent antioxidant activity; as such, Walterolactone A (1a) and B (1b)
β-D-glucopyranoside (13), together with walterolactone A/B 6-O-gallate-β-D-glucopyranoside (9),
which is a new compound investigated in this study, were determined as new effective antioxidants.
Table 2. Evaluation of the antioxidant activity of the isolated compounds.
No. Isolated compounds DPPHFRS50 (µg/mL) Max (%)
1 Umbelactone (new natural product) - -
2 Walterolactone - -
3 Phenylalanine - -
4 2-methoxy-4-hydroxyphenol-1-O-β-D-glucopyranoside 38.09 b 92 a
5 1-β-D-glucopyranosyloxy-3,5-dimethoxy-4-hydroxybenzene 58.11 a 100 a
6 3,4-Dihydroxybenzoic acid 16.77 e 95 a
7 2-benzoyl myo-inositol (new natural product) - -
8 1-O-Benzoyl-myo-inositol (new natural product) - -
9 Walterolactone A/B 6-O-gallate-β-D-glucopyranoside(new compound) 10.9
e,f 96 a
10 Roseoside (6S, 9S) - -
11
(3R*,6R*)-tetrahydro-6-ethenyl-2,2,6-trimethyl-2H-pyran
3-O-α-L-arabinopyranosyl (1→3)-β-D-glucuronopyranosyl
(new compound)
UD 25 b
12 7-Hydroxy-6,7-dihydro-cis/trans-geraniate, 3-O-α-L-arabinopyranosyl (1→6)-β-D-glucupyranosyl (new compound) UD 20
b
13 Walterolactone A (1a) and B (1b) β-D-glucopyranoside 28 c,d 98 a
14 Gallic acid 9 f 97 a
15 (−)-Gallocatechin 30.73 c 93 a
16 1-(4-hydroxyphenyl)-2,3-dihydroxypropan-1-one 3-O-β-D-glucopyranoside/or Schweinfurthinol 9-O-β-D-glucopyranoside - -
17 Myo-inositol 1-O-3,3-dimethylacrylate/or1-O-(3-methyl)-butenoyl-myo-inositol - -
18 Leonuriside 27.47 c,d 95 a
19 (+)-Catechin 7.10 f 97 a
20 Methyl galloate 9.4 f 96 a
21 (−)-Catechin 11.5 e,f 96 a
22 (3,5-dimethoxy-4-hydroxyphenol)-1-O-β-D-(6
′-O-galloyl)-
glucopyranoside 7.8
f 96 a
α-Tocopherol (commercial antioxidant) 23 d 99 a
CV (Coefficient of variation, %) 12.33842 7.156336
The purified compounds were tested for their antioxidant activity at concentrations in the range of 0.5–250 µg/mL.
The results were presented as the means ± SD of multiple tests (n = 3). The means of max inhibition and FRS50
with different letters in the same column were significantly different based on Duncan’s multiple range test at alpha
= 0.01 (UD: unable to determine).
2.5. Anti-Inflammation and Cytotoxicity of Euonymus laxiflorus Champ. Extract and its Major Compounds
Nitric oxide (NO) has been suggested as a mediator of pro-inflammatory activity related to
certain inflammatory disorders, including chronic hepatitis, pulmonary fibrosis, and rheumatoid
arthritis. In this study, the crude extract (ELCTB) and its major identified compounds (1, 2, and
15) were evaluated for anti-NO activity with the use of LPS-stimulated RAW 264.7 cells. As shown
in Figure 5a, Walterolactone A (1a) and B (1b) β-D-glucopyranoside (13) showed the most effective
anti-inflammation properties and gallic acid (14) demonstrated acceptable activity with max inhibition
and IC50 values of 100%, 1.3 µg/mL and 56%, 145 µg/mL, respectively, while (+)-Catechin (19) and the
crude extract possessed weak activity with a max inhibition of 33.7% and 6%, respectively. Quercetin,
a commercial anti-NO compound, was tested for comparison and showed max inhibition and IC50
values of 100%, 1.21 µg/mL, respectively. The results indicated that Walterolactone A (1a) and B (1b)
β-D-glucopyranoside (13) demonstrated promising activity which was equal to that of the positive
control. Notably, Walterolactone A (1a) and B (1b) β-D-glucopyranoside (13) was investigated for the
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efficacy of its anti-NO activity for the first time in the current study and was found to be a new effective
anti-NO compound. In the previous study, a total of 11 constituents were isolated and identified from
the stems and leaves of Euonymus laxiflorus. Of these purified compounds, laxifolone A (a triterpene)
displayed significant anti-NO effects [29].
The cytotoxicity of Euonymus laxiflorus Champ. extract and its major compounds were also
examined using the same cell model based on LPS-stimulated RAW 264.7 cells. The cytotoxicity of
the crude extract and its major identified compounds were tested using a large concentration range of
20–160 µg/mL. The results (Figure 5b) showed that the major isolated compounds of ELCTB all slightly
enhanced the growth of normal cells and that the ELCTB extract, as well as its major compounds (13,
14, and 19), had no toxicity to normal cells. In the previous study [3], The ELCTB extract was reported
to show no toxic effects on a mouse model at a high dose of 300 mg/kg bw (body weight). The results
of this study, as well as those of recently reported researches [3], confirmed that ELCTB was a natural
and safe material with promising biomedical activities, including enzymic inhibition, hypoglycemic
effects, and antidiabetic, antioxidant, and anti-NO activities.
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Figure 5. Anti-NO activity (a), and cy tox city (b) of Euonymus laxiflorus Champ. trunk bark (
extr ct and its isolated compounds, including Walterolactone A (1a) and B (1b) β-D-glucopyranoside
(13), gallic acid (14), and (+)-Catechin (19).
3. Materials and Methods
3.1. Materials
The ELCBT extract was obtained according to a previous study reported by Nguyen et al.,
2017 [11]. 2-diphenyl-1-picrylhydrazyl (DPPH) and ODS gel were purchased from Sigma Chemical
Co. (St. Louis City, MO, USA) and Merck Sigma Chemical Co. (St. Louis City, MO, USA), respectively.
Reagents, other common chemicals, and solvents were available at the highest grade.
3.2. Biological Activity Assays
Free radical scavenging activity was determined through use of the DPPH radical scavenging
activity assay described by Nguyen et al., 2018 [9] with minor modifications. One hundred and twenty
microliters (120 µL) of the samples (diluted with methanol at a concentration range of 0.5–250 µg/mL)
were mixed with 30 µL of 0.75 mM DPPH in methanol in a 96-well plate and then kept in the dark for
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30 min. The optical density of the mixtures at 517 nm (OD517nm) was measured [30]. The following
formula (1) was used to calculate the antioxidant activity:
Activity (%) =
(
A− B
A
)
× 100% (1)
where, A refers to the OD517nm of the blank sample (no antioxidants/samples in the mixture solution)
and B stands for the OD517nm of the sample solution at 30 min of incubation. The concentration of
an antioxidant compound that can reduce 50% of the purple color of the DPPH solution under the
assay conditions was defined as the FRS50 value [9]. α-Tocopherol dissolved in MeOH was used as
the positive control.
An anti-inflammation assay was also performed according to the methods described in detail
by Nguyen et al., 2018 [9]. The tests were all repeated in triplicate and the differences between the
mean values of the antioxidant and anti-NO activity (p < 0.01) were analyzed using Statistical Analysis
Software (SAS-9.4, provided by SAS Institute Taiwan Ltd., Minsheng East Road, Section 2, Taipei,
Taiwan 149-8).
3.3. Purification Procedures and Identification of Active Compounds
A total of 40 g of ELCTB extract were loaded onto a Diaion (Mitsubishi Chemical Co., Tokyo,
Japan) column and primarily separated into five major fractions: ELCTB-1 (20.97 g), ELCTB-2
(9.12 g), ELCTB-3 (4.67 g), ELCTB-4 (1.46 g), and ELCTB-5 (1.63 g) using successive eluting with
distilled water, 40% MeOH, 70% MeOH, 100% MeOH, and 100% ethyl acetate, respectively. ELCTB-2
(4 g) and ELCTB-3 (4 g) were sub-fractionated via the ODS column to obtain 10 sub-fractions
(ELCTB.2.1–ELCTB.2.10) as well as 10 sub-fractions (ELCTB.3.1–ELCTB.3.10) eluted with gradient
mobile phases of 0–100% MeOH in H2O, v/v and 10–100% ACN in H2O, v/v, respectively. Of these,
ELCTB.2.1, ELCTB.2.2, ELCTB.2.3, and ELCTB.3.3, which were eluted with distilled water, 5% MeOH,
10% MeOH, and 20% ACN, respectively, were further injected into preparative HPLC (a preparative
Cosmosil 5C18-AR-II column equipped with 250 × 20 mm i.d. and a UV detector (Nacalai Tesque, Inc.,
Kyoto, Japan) at 221 and 254 nm), to obtain 12 compounds (1–12). Compounds 1–8 were eluted with
5% ACN, compound 11 was eluted with 9% ACN, and compounds 9, 10, and 12 were eluted with 23%
MeOH. The isolation process of the active compounds from the ELCTB extract are briefly summarized
in Figure 1. The chemical structures of the isolated constituents were identified by analysis of their
NMR data and a comparison with the reported compounds. The 1H and 13C-NMR spectra and the
2D-NMR spectra, including NOESY, HMBC, HMQC, and COSY, were measured in MeOH-d4 on
a Bruker AVX NMR spectrometer (Bruker, Karlsruhe, Germany), which operated at 600 MHz for 1–12 h
and 150 MHz for 13C spectra measurement, and the MeOH-d4 solvent peak was used as the internal
standard (δH 3.317, δC 49.1 ppm).
4. Conclusions
A total of 12 phenolics (1–12) were newly isolated and identified from Euonymus laxiflorus.
Of these, three constituents (9), (11), and (12) were identified as new compounds, while (1), (7), and
(8) were identified as new natural products. These 12 compounds and the other 10 compounds
(13–22) obtained from our previous work were evaluated for their antioxidant activity. Notably,
12 compounds (4–6, 9, 13–15, 18–22) displayed potent antioxidant activity (FRS50 = 7.8–58.11 µg/mL)
compared to α-tocopherol (FRS50 = 23 µg/mL). Among these, two constituents, (9) and (13), were
determined to be new antioxidants. In the anti-NO activity tests, walterolactone A (1a) and B (1b)
β-D-glucopyranoside (13) was found to have the most effective and comparable activity to that of
quercetin, with max inhibition and IC50 values of 100%, 1.3 µg/mL and 100%, 1.21 µg/mL, respectively,
and this compound was reported to have anti-NO activity for the first time. The crude extract and its
major compounds showed no cytotoxicity on normal cells. The results of the current study confirmed
that ELCTB was a rich natural source of active phenolics that could be developed as a health food with
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promising antioxidant, anti-NO, and other beneficial biological activities. The results of this study
also contributed to the enrichment of new natural products and the enrichment of novel compounds,
as well as the novel biological activity of the constituents isolated from Euonymus laxiflorus.
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